Bacterial Vaginosis – Pipeline Review, H2 2018 Featuring Evofem Biosciences, Melinta Therapeutics, Osel, Pharmiva, Profarma & Starpharma – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Bacterial
Vaginosis – Pipeline Review, H2 2018”
drug pipelines has been
added to ResearchAndMarkets.com’s offering.

Bacterial Vaginosis – Pipeline Review, H2 2018, provides comprehensive
information on the therapeutics under development for Bacterial
Vaginosis (Infectious Disease), complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases.

The Bacterial Vaginosis (Infectious Disease) pipeline guide also reviews
of key players involved in therapeutic development for Bacterial
Vaginosis and features dormant and discontinued projects. The guide
covers therapeutics under Development by Companies /Universities
/Institutes, the molecules developed by Companies in Pre-Registration,
Phase II, Phase I, Preclinical and Discovery stages are 1, 5, 1, 3 and 1
respectively. Similarly, the Universities portfolio in Discovery stages
comprises 1 molecules, respectively.

Bacterial Vaginosis (Infectious Disease) pipeline guide helps in
identifying and tracking emerging players in the market and their
portfolios, enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Report Coverage
  3. Bacterial Vaginosis – Overview
  4. Bacterial Vaginosis – Therapeutics Development
  5. Pipeline Overview
  6. Pipeline by Companies
  7. Pipeline by Universities/Institutes
  8. Products under Development by Companies
  9. Products under Development by Universities/Institutes
  10. Bacterial Vaginosis – Therapeutics Assessment
  11. Assessment by Target
  12. Assessment by Mechanism of Action
  13. Assessment by Route of Administration
  14. Assessment by Molecule Type
  15. Bacterial Vaginosis – Companies Involved in Therapeutics Development
  • Evofem Biosciences Inc
  • Melinta Therapeutics Inc
  • Osel Inc
  • Pharmiva AB
  • Profarma
  • Starpharma Holdings Ltd

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/t6drm9/bacterial?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Infectious
Diseases Drugs